Download App

Log in to access Online Inquiry
Company Overview More
Cryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities is maintained throughout the shipping cycle. It also provides information dashboards and validation documentation for shipments through data collected by the SmartPak Condition Monitoring System; and vacuum insulated aluminum dewars and cryogenic freezers systems. In addition, the company offers biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; transportation of frozen biological specimens to and from customer locations; and management of incoming and outgoing biological specimens, as well as provides logistics support and management; and short-term logistics and engineering consulting services. It serves biopharma/pharma, animal health, and human reproductive medicine markets. The company was founded in 1999 and is headquartered in Brentwood, Tennessee.
CEO: Shelton, Jerrell W.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

CYRX Cryoport
23.400+0.130+0.56%
Post Mkt Price
23.40000.00%
YOY
Do not show
Hide blank lines
(Q1)2022/03/31(FY)2021/12/31(Q4)2021/12/31(Q3)2021/09/30
Assets
Current assets
Cash, cash equivalents and short term investments
69.73% 599.51M 573.83% 628.8M 573.83% 628.8M 72.21% 349.48M
-Cash and cash equivalents
57.26% 134.45M 277.24% 139.1M 277.24% 139.1M -73.03% 43.68M
-Short-term investments
73.71% 465.06M 767.58% 489.7M 767.58% 489.7M 646.72% 305.8M
Receivables
-1.83% 35.84M 25.61% 39.41M 25.61% 39.41M 394.12% 38.46M
-Accounts receivable
-1.83% 35.84M 25.61% 39.41M 25.61% 39.41M 394.12% 38.46M
Inventory
91.11% 22.06M 56.63% 16.5M 56.63% 16.5M 2729.08% 13.48M
Prepaid assets
-54.76% 8.36M -26.19% 8.8M -26.19% 8.8M 520.23% 8.96M
Total current assets
58.61% 665.77M 371.28% 693.52M 371.28% 693.52M 92.99% 410.38M
Non current assets
Net PPE
44.02% 68.68M 58.13% 69.7M 58.13% 69.7M 163.08% 61.28M
-Gross PPE
44.02% 68.68M 50.53% 89.7M 58.13% 69.7M 163.08% 61.28M
-Accumulated depreciation
-- -- -28.93% -20M -- -- -- --
Goodwill and other intangible assets
-1.82% 344.2M -3.01% 348.38M -3.01% 348.38M 2112.66% 351.61M
-Goodwill
3.74% 146.59M 1.15% 146.95M 1.15% 146.95M 1230.68% 146.37M
-Other intangible assets
-5.57% 197.61M -5.83% 201.43M -5.83% 201.43M 4096.17% 205.24M
Non current deferred assets
-- 1.73M -- -- -- -- -- --
Non current prepaid assets
-0.21% 944K -19.76% 950K -19.76% 950K 78.25% 955K
Other non current assets
-- -- -47.23% 419K -47.23% 419K -- 158K
Total non current assets
3.9% 415.56M 3.51% 419.45M 3.51% 419.45M 942.32% 414M
Total assets
31.92% 1.08B 101.48% 1.11B 101.48% 1.11B 226.67% 824.39M
Liabilities
Current liabilities
Payables
-- -- 15.05% 28.58M -- -- -- --
-accounts payable
-- -- 15.05% 28.58M -- -- -- --
Current accrued expenses
-- -- 33.21% 9.91M -- -- -- --
Current debt and capital lease obligation
68.09% 3.47M 57.34% 3.6M 57.34% 3.6M 294.36% 2.88M
-Current capital lease obligation
68.09% 3.47M 57.34% 3.6M 57.34% 3.6M 294.36% 2.88M
Current deferred liabilities
4.44% 517K 22.92% 547K 22.92% 547K 29.97% 308K
Other current liabilities
-- 53K -- -- -- -- -- --
Current liabilities
17.34% 44.44M 21.77% 42.65M 21.77% 42.65M 211.5% 41.07M
Non current liabilities
Long term debt and capital lease obligation
225.04% 421.35M 229.2% 423.45M 229.2% 423.45M 11.55% 132.85M
-Long term debt
252.81% 405.85M 248.59% 405.26M 248.59% 405.26M 4.75% 116.43M
-Long term capital lease obligation
6.17% 15.49M 47.05% 18.2M 47.05% 18.2M 106.83% 16.42M
Non current deferred liabilities
8.13% 5M -31.69% 4.02M -31.69% 4.02M 4814.17% 2.36M
Other non current liabilities
261.56% 1.11M 483.52% 1.03M 483.52% 1.03M -- 879K
Total non current liabilities
217.67% 427.46M 218.14% 428.5M 218.14% 428.5M 14.22% 136.09M
Total liabilities
173.67% 471.9M 177.62% 471.14M 177.62% 471.14M 33.88% 177.16M
Shareholders'equity
Share capital
185.3% 12.33M 258.01% 10.33M -- -- 21244.65% 8.32M
-common stock
11.11% 50K 25% 50K -- -- 18% 46K
-Preferred stock
187.13% 12.28M 261.29% 10.28M -- -- -- 8.28M
Retained earnings
-150.23% -489.29M -143.49% -467.54M -- -- -14.94% -207.46M
Paid-in capital
31.65% 1.1B 94.24% 1.1B -- -- 181.81% 846.19M
Gains losses not affecting retained earnings
-1954.77% -16.32M -123.12% -1.24M -- -- -16.27% 173K
Total stockholders'equity
-5.85% 609.43M 67.71% 641.83M 67.71% 641.83M 439.19% 647.23M
Total equity
-5.85% 609.43M 67.71% 641.83M 67.71% 641.83M 439.19% 647.23M
Currency Unit
USDUSDUSDUSD
Accounting Standards
US-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions
--Unqualified Opinion----

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%